Lv612
2550 积分 2024-05-26 加入
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study
24天前
已完结
Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion
1个月前
已完结
A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans
2个月前
已关闭
Plasmacytoid Dendritic Cell Receptor BDCA2/FcεRγ Complex Uses BCR-like Signaling Cascade to Modulate Toll-Like Receptor Responses (89.20)
2个月前
已关闭
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2个月前
已完结
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2个月前
已完结
Expert consensus on the application and management of therapeutic drugs for atopic dermatitis （2024）
2个月前
已完结
Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
3个月前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial
3个月前
已完结
Mini-PBPK-Based Population Model and Covariate Analysis to Assess the Complex Pharmacokinetics and Pharmacodynamics of RO7449135, an Anti-KLK5/KLK7 Bispecific Antibody in Cynomolgus Monkeys
3个月前
已完结
皖公网安备34019202002308
